Skip to main content
Top
Published in: BMC Oral Health 1/2022

Open Access 01-12-2022 | Diffuse Large B-Cell Lymphoma | Research article

Clinical manifestations of diffuse large B-cell lymphoma that exhibits initial symptoms in the maxilla and mandible: a single-center retrospective study

Authors: Yasuyuki Michi, Hiroyuki Harada, Yu Oikawa, Kohei Okuyama, Takuma Kugimoto, Takeshi Kuroshima, Hideaki Hirai, Yumi Mochizuki, Hiroaki Shimamoto, Hirofumi Tomioka, Hirokazu Kachi, Jun-ichiro Sakamoto, Kou Kayamori, Tetsuya Yoda

Published in: BMC Oral Health | Issue 1/2022

Login to get access

Abstract

Background

Diffuse large B-cell lymphoma (DLBCL) is the most common type of lymphatic tumor; however, extranodal DLBCLs that exhibit initial symptoms in the maxilla and mandible are rare. Moreover, DLBCL is clinically classified as a moderate to highly malignant lymphatic tumor that can progress rapidly; therefore, early diagnosis is crucial. However, diagnosis is difficult as the disease causes a diverse range of clinical symptoms with no characteristic imaging findings. We conducted a clinical investigation to clarify the clinical characteristics of DLBCL that exhibits initial manifestation in the maxilla and mandible.

Methods

Of the 2748 patients with malignant tumors of the oral and maxillofacial region examined at our hospital during a period of 11 years between January 2006 and December 2016, 27 primary cases diagnosed with DLBCL based on the chief complaint of symptoms in the gingiva and bone of the maxilla and mandible were enrolled in this study. Evaluations were based on sex, age, whether treatment was provided by a previous physician, symptoms, duration of disease until treatment was sought, clinical diagnosis, laboratory findings, and imaging results.

Results

There were 15 cases that involved the maxilla and 12 that involved the mandible. The median duration of disease until treatment was sought was 60 d (3–450 d). All cases exhibited a tumor or a mass, and hypoesthesia of the chin was confirmed in eight cases wherein the mandible was involved. The clinical stages were stage I in eight cases, stage II in ten cases, and stage IV in nine cases. Serum lactate dehydrogenase (LDH) levels were elevated in 13 of 22 patients. The overall survival rate was 63%.

Conclusions

Symptoms associated with nontender swelling and numbness of the lip or chin in the absence of other findings such as dental infections should raise suspicions about DLBCL. Patients should be provided appropriate imaging and accurate biopsy assessments to improve prognosis.
Literature
1.
go back to reference Li S, Young KH, Medeiros LJ. Diffuse large B-cell lymphoma. Pathology. 2018;50:74–87.CrossRef Li S, Young KH, Medeiros LJ. Diffuse large B-cell lymphoma. Pathology. 2018;50:74–87.CrossRef
2.
go back to reference Rosado MF, Morgensztern D, Peleg M, Lossos IS. Primary diffuse large cell lymphoma of the mandible. Leuk Lymphoma. 2004;45:1049–53.CrossRef Rosado MF, Morgensztern D, Peleg M, Lossos IS. Primary diffuse large cell lymphoma of the mandible. Leuk Lymphoma. 2004;45:1049–53.CrossRef
3.
go back to reference Zou H, Yang H, Zou Y, Lei L, Song L. Primary diffuse large B-cell lymphoma in the maxilla: a case report. Medicine (Baltimore). 2018;97:e10707.CrossRef Zou H, Yang H, Zou Y, Lei L, Song L. Primary diffuse large B-cell lymphoma in the maxilla: a case report. Medicine (Baltimore). 2018;97:e10707.CrossRef
4.
go back to reference Rodrigues-Fernandes CI, Junior AG, Soares CD, Morais TML, do Amaral-Silva GK, de Carvalho MGF, et al. Oral and oropharyngeal diffuse large B-cell lymphoma and high-grade B-cell lymphoma: A clinicopathologic and prognostic study of 69 cases. Oral Surg Oral Med Oral Pathol Oral Radiol. 2021;131:452-62.e4.CrossRef Rodrigues-Fernandes CI, Junior AG, Soares CD, Morais TML, do Amaral-Silva GK, de Carvalho MGF, et al. Oral and oropharyngeal diffuse large B-cell lymphoma and high-grade B-cell lymphoma: A clinicopathologic and prognostic study of 69 cases. Oral Surg Oral Med Oral Pathol Oral Radiol. 2021;131:452-62.e4.CrossRef
5.
go back to reference Tseng CH, Wang WC, Chen CY, Hsu HJ, Chen YK. Clinical manifestations of oral lymphomas—retrospective study of 15 cases in a Taiwanese population and a review of 592 cases from the literature. J Formos Med Assoc. 2021;120:361–70.CrossRef Tseng CH, Wang WC, Chen CY, Hsu HJ, Chen YK. Clinical manifestations of oral lymphomas—retrospective study of 15 cases in a Taiwanese population and a review of 592 cases from the literature. J Formos Med Assoc. 2021;120:361–70.CrossRef
6.
go back to reference Triantafillidou K, Dimitrakopoulos J, Iordanidis F, Gkagkalis A. Extranodal non-hodgkin lymphomas of the oral cavity and maxillofacial region: a clinical study of 58 cases and review of the literature. J Oral Maxillofac Surg. 2012;70:2776–85.CrossRef Triantafillidou K, Dimitrakopoulos J, Iordanidis F, Gkagkalis A. Extranodal non-hodgkin lymphomas of the oral cavity and maxillofacial region: a clinical study of 58 cases and review of the literature. J Oral Maxillofac Surg. 2012;70:2776–85.CrossRef
7.
go back to reference Shiraishi T, Chikui T, Inadomi D, Hashimoto M, Horio C, Kagawa T, et al. MRI findings of extranodal malignant lymphoma and squamous cell carcinoma in the head and neck regions. Oral Radiol. 2016;32:98–104.CrossRef Shiraishi T, Chikui T, Inadomi D, Hashimoto M, Horio C, Kagawa T, et al. MRI findings of extranodal malignant lymphoma and squamous cell carcinoma in the head and neck regions. Oral Radiol. 2016;32:98–104.CrossRef
8.
go back to reference Elstrom R, Guan L, Baker G, Nakhoda K, Vergilio JA, Zhuang H, et al. Utility of FDG-PET scanning in lymphoma by WHO classification. Blood. 2003;101:3875–6.CrossRef Elstrom R, Guan L, Baker G, Nakhoda K, Vergilio JA, Zhuang H, et al. Utility of FDG-PET scanning in lymphoma by WHO classification. Blood. 2003;101:3875–6.CrossRef
9.
go back to reference Epstein JB, Epstein JD, Le ND, Gorsky M. Characteristics of oral and paraoral malignant lymphoma: a population-based review of 361 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;92:519–25.CrossRef Epstein JB, Epstein JD, Le ND, Gorsky M. Characteristics of oral and paraoral malignant lymphoma: a population-based review of 361 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;92:519–25.CrossRef
10.
go back to reference van der Waal RI, Huijgens PC, van der Valk P, van der Waal I. Characteristics of 40 primary extranodal non-Hodgkin lymphomas of the oral cavity in perspective of the new WHO classification and the International Prognostic Index. Int J Oral Maxillofac Surg. 2005;34:391–5.CrossRef van der Waal RI, Huijgens PC, van der Valk P, van der Waal I. Characteristics of 40 primary extranodal non-Hodgkin lymphomas of the oral cavity in perspective of the new WHO classification and the International Prognostic Index. Int J Oral Maxillofac Surg. 2005;34:391–5.CrossRef
11.
go back to reference Morton LM, Turner JJ, Cerhan JR, Linet MS, Treseler PA, Clarke CA, et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (Inter Lymph). Blood. 2007;110:695–708.CrossRef Morton LM, Turner JJ, Cerhan JR, Linet MS, Treseler PA, Clarke CA, et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (Inter Lymph). Blood. 2007;110:695–708.CrossRef
12.
go back to reference Ohmachi K. JSH practical guidelines for hematological malignancies, 2018: II. Lymphoma-5-diffuse large B-cell lymphoma, not otherwise specified (DLBCL, NOS). Int J Hematol. 2019;110:131–46.CrossRef Ohmachi K. JSH practical guidelines for hematological malignancies, 2018: II. Lymphoma-5-diffuse large B-cell lymphoma, not otherwise specified (DLBCL, NOS). Int J Hematol. 2019;110:131–46.CrossRef
13.
go back to reference Mortazavi H, Baharvan M, Rezaeifar K. Periapical lymphoma: review of reported cases in the literature. J Stomatol Oral Maxillofac Surg. 2020;121:404–7.CrossRef Mortazavi H, Baharvan M, Rezaeifar K. Periapical lymphoma: review of reported cases in the literature. J Stomatol Oral Maxillofac Surg. 2020;121:404–7.CrossRef
14.
go back to reference Fuessinger MA, Voss P, Metzger MC, Zegpi C, Semper-Hogg W. Numb chin as signal for malignancy-primary intraosseous diffuse large B-cell. Ann Maxillofac Surg. 2018;8:143–6.CrossRef Fuessinger MA, Voss P, Metzger MC, Zegpi C, Semper-Hogg W. Numb chin as signal for malignancy-primary intraosseous diffuse large B-cell. Ann Maxillofac Surg. 2018;8:143–6.CrossRef
15.
go back to reference Kolokotronis A, Konstantinou N, Christakis I, Papadimitriou P, Matiakis A, Zaraboukas T, et al. Localized B-cell non-Hodgkin’s lymphoma of oral cavity and maxillofacial region: a clinical study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;99:303–10.CrossRef Kolokotronis A, Konstantinou N, Christakis I, Papadimitriou P, Matiakis A, Zaraboukas T, et al. Localized B-cell non-Hodgkin’s lymphoma of oral cavity and maxillofacial region: a clinical study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;99:303–10.CrossRef
16.
go back to reference Storck K, Brandstetter M, Keller U, Knopf A. Clinical presentation and characteristics of lymphoma in the head and neck region. Head Face Med. 2019;15:1.CrossRef Storck K, Brandstetter M, Keller U, Knopf A. Clinical presentation and characteristics of lymphoma in the head and neck region. Head Face Med. 2019;15:1.CrossRef
17.
go back to reference Ramprakash CH, Padmashree S, Rema J. Primary intraosseous lymphoma of the maxilla—a case report and review of literature. J Oral Maxillofac Surg Med Pathol. 2015;27:712–21.CrossRef Ramprakash CH, Padmashree S, Rema J. Primary intraosseous lymphoma of the maxilla—a case report and review of literature. J Oral Maxillofac Surg Med Pathol. 2015;27:712–21.CrossRef
18.
go back to reference Imaizumi A, Kuribayashi A, Watanabe H, Ohbayashi N, Nakamura S, Sumi Y, et al. Non-Hodgkin lymphoma involving the mandible: imaging findings. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;113:e33–9.CrossRef Imaizumi A, Kuribayashi A, Watanabe H, Ohbayashi N, Nakamura S, Sumi Y, et al. Non-Hodgkin lymphoma involving the mandible: imaging findings. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;113:e33–9.CrossRef
19.
go back to reference Tsujioka T, Kishimoto M, Kondo T, Matsuoka A, Tasaka T, Sugihara T, et al. The impact of serum soluble interleukin-2 receptor levels on the diagnosis of malignant lymphoma. Kawasaki Med J. 2011;37:19–27. Tsujioka T, Kishimoto M, Kondo T, Matsuoka A, Tasaka T, Sugihara T, et al. The impact of serum soluble interleukin-2 receptor levels on the diagnosis of malignant lymphoma. Kawasaki Med J. 2011;37:19–27.
Metadata
Title
Clinical manifestations of diffuse large B-cell lymphoma that exhibits initial symptoms in the maxilla and mandible: a single-center retrospective study
Authors
Yasuyuki Michi
Hiroyuki Harada
Yu Oikawa
Kohei Okuyama
Takuma Kugimoto
Takeshi Kuroshima
Hideaki Hirai
Yumi Mochizuki
Hiroaki Shimamoto
Hirofumi Tomioka
Hirokazu Kachi
Jun-ichiro Sakamoto
Kou Kayamori
Tetsuya Yoda
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Oral Health / Issue 1/2022
Electronic ISSN: 1472-6831
DOI
https://doi.org/10.1186/s12903-022-02056-x

Other articles of this Issue 1/2022

BMC Oral Health 1/2022 Go to the issue